Covered recipient · General Payments record
BARRY R AUSTIN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2021
$4,414.84
- Reported across 310 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $394.44 | 22 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $232.33 | 13 |
| Amarin Pharma Inc. | $42.86 | 2 |
| GlaxoSmithKline, LLC. | $21.60 | 1 |
| Lilly USA, LLC | $19.74 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.18 | 1 |
| Astellas Pharma US Inc | $16.89 | 1 |
| Novo Nordisk AS | $14.73 | 1 |
| Biohaven Pharmaceuticals, Inc. | $14.53 | 1 |
| Janssen Pharmaceuticals, Inc | $12.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (22)
Sorted by paying entity, then date · as published by CMS
Program year 2021 201820192020
Record-level detail is published for PY2021; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $14.84 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939243 | CMS |
| AbbVie Inc. | $17.14 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939247 | CMS |
| AbbVie Inc. | $1.76 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939251 | CMS |
| AbbVie Inc. | $20.34 | 05/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939255 | CMS |
| AbbVie Inc. | $16.96 | 06/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939259 | CMS |
| AbbVie Inc. | $29.42 | 08/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939263 | CMS |
| AbbVie Inc. | $15.76 | 09/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939267 | CMS |
| AbbVie Inc. | $23.08 | 09/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939271 | CMS |
| AbbVie Inc. | $16.82 | 09/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939275 | CMS |
| AbbVie Inc. | $22.83 | 10/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939279 | CMS |
| AbbVie Inc. | $17.64 | 11/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939283 | CMS |
| AbbVie Inc. | $22.95 | 11/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939287 | CMS |
| AbbVie Inc. | $12.79 | 12/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 793939291 | CMS |
| Amarin Pharma Inc. | $20.93 | 01/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815446561 | CMS |
| Amarin Pharma Inc. | $21.93 | 03/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815300013 | CMS |
| Astellas Pharma US Inc | $16.89 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 821251567 | CMS |
| Biohaven Pharmaceuticals, Inc. | $14.53 | 03/18/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852411395 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $19.18 | 03/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763559686 | CMS |
| GlaxoSmithKline, LLC. | $21.60 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 801819119 | CMS |
| Janssen Pharmaceuticals, Inc | $12.58 | 02/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 788588637 | CMS |
| Lilly USA, LLC | $19.74 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818963093 | CMS |
| Novo Nordisk Inc | $14.73 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836093299 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.